News related to Alimta (Pemetrexed) and/or conditions it is approved for
Lung Cancer: Expanded Alimta Label
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has expanded the indication for the cancer drug pemetrexed injection to act as a maintenance therapy with cisplatin for nonsquamous non-small cell lung cancer.
Docetaxel or pemetrexed with cisplatin achieve comparable outcomes in non-squamous lung cancer
Source: Lung Cancer News From Medical News Today [2014.09.29]
The first direct comparison of treating non-squamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free...